Clinical Trial Update: Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of Tregalizumab in MTX-IR active rheumatoid arthritis was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tregalizumab (regalizumab)

Snippet

Sponsor: Biotest | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2017-08-24